These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21382136)

  • 1. Genetics/epigenetics of oral premalignancy: current status and future research.
    Lingen MW; Pinto A; Mendes RA; Franchini R; Czerninski R; Tilakaratne WM; Partridge M; Peterson DE; Woo SB
    Oral Dis; 2011 Apr; 17 Suppl 1():7-22. PubMed ID: 21382136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics of premalignant oral lesions.
    Mithani SK; Mydlarz WK; Grumbine FL; Smith IM; Califano JA
    Oral Dis; 2007 Mar; 13(2):126-33. PubMed ID: 17305612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spanish dental students knowledge of oral malignancy and premalignancy.
    Jaber MA; Diz Dios P; Vázquez García E; Cutando Soriano A; Porter SR
    Eur J Dent Educ; 1997 Nov; 1(4):167-71. PubMed ID: 9516286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of oral lichen planus. A premalignant lesion?
    Zhang L; Michelsen C; Cheng X; Zeng T; Priddy R; Rosin MP
    Am J Pathol; 1997 Aug; 151(2):323-7. PubMed ID: 9250145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis of oral premalignant and malignant lesions.
    Epstein JB; Zhang L; Rosin M
    J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
    Epstein JB; Sciubba J; Silverman S; Sroussi HY
    Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease mechanism and biomarkers of oral squamous cell carcinoma.
    Brinkman BM; Wong DT
    Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
    Chen YK; Hsue SS; Lin LM
    Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular markers in oral epithelial dysplasia: review.
    Pitiyage G; Tilakaratne WM; Tavassoli M; Warnakulasuriya S
    J Oral Pathol Med; 2009 Nov; 38(10):737-52. PubMed ID: 19903246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potentially malignant disorders of the oral mucosa: terminology and classification].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):208-12. PubMed ID: 20739038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.
    Hsieh PC; Chen YK; Tsai KB; Shieh TY; Chang YY; Chang JG; Wu HL; Lin SF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):257-67. PubMed ID: 19926498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
    Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
    J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [P53 expression and clinical significance in oral squamous cell carcinoma].
    Long Y; Ling D; Yue W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the tissue marker AgNOR in leukoplaquia and oral squamous cell carcinoma.
    Cano Montoya LC; Alvarez Gómez GJ; Valencia Londoño WA; Ramírez España JA; Prada Navas CA
    Med Oral; 2002; 7(1):17-21, 22-5. PubMed ID: 11788805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of molecular markers to predict malignant potential of oral precancer.
    Warnakulasuriya S
    J Pathol; 2000 Mar; 190(4):407-9. PubMed ID: 10699986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.
    Gasco M; Bell AK; Heath V; Sullivan A; Smith P; Hiller L; Yulug I; Numico G; Merlano M; Farrell PJ; Tavassoli M; Gusterson B; Crook T
    Cancer Res; 2002 Apr; 62(7):2072-6. PubMed ID: 11929827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.